Indonesia Digital Diabetes Management Market Outlook 2020-2030

Indonesia Digital Diabetes Management Market Analysis 2020-2030

The Indonesia digital diabetes management market is anticipated to grow with a CAGR of 17.97% during the forecast period, i.e., 2021-2030. Factors such as the increasing prevalence of diabetes in Indonesia, along with the growing adoption of digital health solutions to tackle the disease are projected to contribute to the growth of the market in the coming years. Besides this, factors such as the increasing advancement in healthcare technologies, rising internet population in Indonesia, and the numerous benefits associated with digital diabetes management solutions are expected to drive the growth of the market in the coming years. The Indonesia digital diabetes management market is estimated to garner a revenue of near to USD 610 Million by the end of 2030, up from a revenue of around USD 120 Million in the year 2020.

The Indonesia digital diabetes management market is segmented by numerous segments, which include segmentation by product & service, device type, diabetes type, and by end-user. Based on end-user, the market is segmented into home care settings, hospitals & specialty diabetes clinics, academic & research institutes, sports & gym centers, and others. The hospitals & specialty diabetes clinics segment, out of all the other segments, is anticipated to garner the largest revenue of about USD 210 Million by the end of 2030. Moreover, in the year 2020, the segment generated the largest revenue of near to USD 40 Million.

Some of the prominent industry leaders in the Indonesia digital diabetes management market that are included in our report are Brighter AB, F.Hoffmann-La Roche Ltd, Medtronic, Azumio Inc., Smart Meter LLC, Abbott, B. Braun Melsungen AG, Biocon, Becton, Dickinson and Company, and others.